Multicenter Collaborative Research on Molecularly Targeted Drug Therapy for Advanced Hepatocellular Carcinoma

Multicenter Collaborative Research on Molecularly Targeted Drug Therapy for Advanced Hepatocellular Carcinoma - Multicenter Collaborative Research on Molecularly Targeted Drug Therapy for Advanced Hepatocellular Carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037041

Enrollment

100

Registered

2019-07-01

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: TACE refractory patients with advanced liver cancer

Exclusion criteria

Exclusion criteria: Patients who are allergic to molecularly targeted drugs Patients who were able to confirm their intention to refuse participation

Design outcomes

Primary

Measure	Time frame
overall survival,progression-free survival	—

Countries

Japan

Contacts

Public ContactNaotaka Shimozato

Nara Medical University Third Department of Internal Medicine

shimozato@naramed-u.ac.jp0744223051

Outcome results